Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey

Grants

Funding Acknowledgements

We thank Susan Chernenko for her assistance in compiling the contact details of the LTx clinicians. This study was partly funded by an educational grant from Gilead-Australia and New Zealand. The company was not involved in the study design, data analysis or manuscript preparation. A PhD scholarship to C.F.N. by University of Technology MARA is gratefully acknowledged.The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. C.O.M. has been a consultant to, received investigator-initiated grant support from and given lectures for Gilead Sciences, Pfizer, Merck, Schering-Plough and Orphan Australia. M. A. S. has sat on advisory boards for and received research funding from Pfizer, Merck, Schering-Plough and Gilead Sciences.